Brief Survey of Current Oral Tobacco and Nicotine Product Use in Sweden and Denmark

1. U.S. Department of Health and Human Services (DHHS), Centers for Desease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, and Office on Smoking and Health: The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General; DHHS, Atlanta, GA, USA, 2014. Available at: https://pubmed.ncbi.nlm.nih.gov/24455788/ (accessed July, 2023). U.S. Department of Health and Human Services (DHHS), Centers for Desease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, and Office on Smoking and Health The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General DHHS Atlanta, GA, USA 2014 Available at: https://pubmed.ncbi.nlm.nih.gov/24455788/ (accessed July, 2023) Search in Google Scholar

2. Gottlieb, S.: Protecting American Families: Comprehensive Approach to Nicotine and Tobacco; Speech by Scott Gottlieb, FDA, White Oak, MD, USA, 28 June 2017. Available at: https://www.fda.gov/news-events/speeches-fda-officials/protecting-americanfamilies-comprehensive-approach-nicotine-and-tobacco-06282017 (accessed July, 2023) GottliebS. Protecting American Families: Comprehensive Approach to Nicotine and Tobacco Speech by GottliebScott FDA White Oak, MD, USA 28 June 2017 Available at: https://www.fda.gov/news-events/speeches-fda-officials/protecting-americanfamilies-comprehensive-approach-nicotine-and-tobacco-06282017 (accessed July, 2023) Search in Google Scholar

3. Royal College of Physicians: Nicotine without Smoke: Tobacco Harm Reduction; RCP, London, UK, 2016. Available at: http://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed July, 2023) Royal College of Physicians: Nicotine without Smoke: Tobacco Harm Reduction RCP London, UK 2016 Available at: http://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction (accessed July, 2023) Search in Google Scholar

4. Public Health England: Health Matters: Stopping Smoking – What Works?; Public Health England, London, UK, 2016. Available at: https://www.gov.uk/government/publications/health-matters-stopping-smoking-what-works/health-matters-stopping-smoking-what-works (accessed July, 2023) Public Health England: Health Matters: Stopping Smoking – What Works? Public Health England London, UK 2016 Available at: https://www.gov.uk/government/publications/health-matters-stopping-smoking-what-works/health-matters-stopping-smoking-what-works (accessed July, 2023) Search in Google Scholar

5. Institute of Medicine (U.S.) Committee to Assess the Science Base for Tobacco Harm Reduction: Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; edited by K. Stratton, P. Shetty, R. Wallace, and S. Bondurant, National Academies Press Washington, DC, USA, 2001. DOI: 10.17226/10029 Institute of Medicine (U.S.) Committee to Assess the Science Base for Tobacco Harm Reduction: Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction edited by StrattonK. ShettyP. WallaceR. BondurantS. National Academies Press Washington, DC, USA 2001 10.17226/10029 Open DOISearch in Google Scholar

6. Foulds, J., L. Ramstrom, M. Burke, and K. Fager-ström: Effect of Smokeless Tobacco (Snus) on Smoking and Public Health in Sweden; Tob. Control 12 (2003) 349–359. DOI: 10.1136/tc.12.4.349 FouldsJ. RamstromL. BurkeM. Fager-strömK. Effect of Smokeless Tobacco (Snus) on Smoking and Public Health in Sweden Tob. Control 12 2003 349 359 10.1136/tc.12.4.349 Open DOISearch in Google Scholar

7. Gartner, C.E., W.D. Hall, T. Vos, M.Y. Bertram, A.L. Wallace, and S.S. Lim: Assessment of Swedish Snus for Tobacco Harm Reduction: An Epidemiological Modelling Study; Lancet 369 (2007) 2010–2014. DOI: 10.1016/S0140-6736(07)60677-1 GartnerC.E. HallW.D. VosT. BertramM.Y. WallaceA.L. LimS.S. Assessment of Swedish Snus for Tobacco Harm Reduction: An Epidemiological Modelling Study Lancet 369 2007 2010 2014 10.1016/S0140-6736(07)60677-1 Open DOISearch in Google Scholar

8. Environ: Review of the Scientific Literature on Snus; Environ, Arlington, VA, USA, 2010. Available at: https://www.swedishmatch.com/globalassets/documents/other/environ-review-of-the-scientific-literature-on-snus-3-31-10.pdf (accessed July, 2023) Environ: Review of the Scientific Literature on Snus Environ Arlington, VA, USA 2010 Available at: https://www.swedishmatch.com/globalassets/documents/other/environ-review-of-the-scientific-literature-on-snus-3-31-10.pdf (accessed July, 2023) Search in Google Scholar

9. Lee, P.N.: The Effect on Health of Switching from Cigarettes to Snus – A Review; Regul. Toxicol. Pharmacol. 66 (2013) 1–5. DOI: 10.1016/j.yrtph.2013.02.010 LeeP.N. The Effect on Health of Switching from Cigarettes to Snus – A Review Regul. Toxicol. Pharmacol 66 2013 1 510.1016/j.yrtph.2013.02.010 Open DOISearch in Google Scholar

10. Ramboll: Systematic Review and Update of the Literature on the Health Effects of Swedish Snus; Ramboll, Arlington, VA, USA, 2019. Available at: http://www.swedishmatch.com/globalassets/documents/other/ramboll-health-effects-update-report_20190513.pdf (accessed July, 2023). Ramboll: Systematic Review and Update of the Literature on the Health Effects of Swedish Snus Ramboll Arlington, VA, USA 2019 Available at: http://www.swedishmatch.com/globalassets/documents/other/ramboll-health-effects-update-report_20190513.pdf (accessed July, 2023) Search in Google Scholar

11. Clarke, E., K. Thompson, S. Weaver, J. Thompson, and G. O’Connell: Snus: A Compelling Harm Reduction Alternative to Cigarettes; Harm Reduct. J. 16 (2019) 62. DOI: 10.1186/s12954-019-0335-1 ClarkeE. ThompsonK. WeaverS. ThompsonJ. O’ConnellG. Snus: A Compelling Harm Reduction Alternative to Cigarettes Harm Reduct. J. 16 2019 62 10.1186/s12954-019-0335-1 Open DOISearch in Google Scholar

12. Ferlay, J., E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, D. Forman, and F. Bray: Cancer Incidence and Mortality Patterns inEurope: Estimates for 40 Countries in 2012; Eur. J. Cancer, 49 (2013) 1374–1403. DOI: 10.1016/j.ejca.2012.12.027 FerlayJ. Steliarova-FoucherE. Lortet-TieulentJ. RossoS. CoeberghJ.W. ComberH. FormanD. BrayF. Cancer Incidence and Mortality Patterns inEurope: Estimates for 40 Countries in 2012 Eur. J. Cancer 49 2013 1374 1403 10.1016/j.ejca.2012.12.027 Open DOISearch in Google Scholar

13. European Commission: Special Eurobarometer 458. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes; 2017. Available at: http://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/Survey/getSurveyDetail/instruments/SPECIAL/surveyKy/2146 (accessed July, 2023) European Commission: Special Eurobarometer 458. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes 2017 Available at: http://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/Survey/getSurveyDetail/instruments/SPECIAL/surveyKy/2146 (accessed July, 2023) Search in Google Scholar

14. World Health Organization (WHO): European Tobacco Use: Trends Report 2019; WHO, Regional Office for Europe, Copenhagen, DK. Available at: https://apps.who.int/iris/handle/10665/346817 (accessed July, 2023) World Health Organization (WHO) European Tobacco Use: Trends Report 2019 WHO, Regional Office for Europe Copenhagen, DK Available at: https://apps.who.int/iris/handle/10665/346817 (accessed July, 2023) Search in Google Scholar

15. U.S. Federal Food and Drug Association (FDA): FDA Grants First-Ever Modified Risk Orders to Eight Smokeless Tobacco Products; FDA, Silver Spring, MD, USA, 2019. Available at: https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products (accessed July, 2023) U.S. Federal Food and Drug Association (FDA) FDA Grants First-Ever Modified Risk Orders to Eight Smokeless Tobacco Products FDA Silver Spring, MD, USA 2019 Available at: https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products (accessed July, 2023) Search in Google Scholar

16. Song, M.A., C. Marian, T.M. Brasky, S. Reisinger, M. Djordjevic, and P.G. Shields: Chemical and Toxicological Characteristics of Conventional and Low-TSNA Moist Snuff Tobacco Products; Toxicol. Lett. 245 (2016) 68–77. DOI: 10.1016/j.toxlet.2016.01.012 SongM.A. MarianC. BraskyT.M. ReisingerS. DjordjevicM. ShieldsP.G. Chemical and Toxicological Characteristics of Conventional and Low-TSNA Moist Snuff Tobacco Products Toxicol. Lett 245 2016 68 7710.1016/j.toxlet.2016.01.012 Open DOISearch in Google Scholar

17. Lawler, T.S., S.B. Stanfill, H.T. Tran, G.E. Lee, P.X. Chen, J.B. Kimbrell, J.G. Lisko, C. Fernandez, S.P. Caudill, B.R. deCastro, and C.H. Watson: Chemical Analysis of Snus Products from the United States and Northern Europe; PLoS One 15 (2020) e0227837. DOI: 10.1371/journal.pone.0227837 LawlerT.S. StanfillS.B. TranH.T. LeeG.E. ChenP.X. KimbrellJ.B. LiskoJ.G. FernandezC. CaudillS.P. deCastroB.R. WatsonC.H. Chemical Analysis of Snus Products from the United States and Northern Europe PLoS One 15 2020 e0227837 10.1371/journal.pone.0227837 Open DOISearch in Google Scholar

18. Benowitz, N.L.: Emerging Nicotine Delivery Products. Implications for Public Health; Ann. Am. Thorac. Soc. 11 (2014) 231–235. DOI: 10.1513/AnnalsATS.201312-433PS BenowitzN.L. Emerging Nicotine Delivery Products. Implications for Public Health Ann. Am. Thorac. Soc 11 2014 231 23510.1513/AnnalsATS.201312-433PS Open DOISearch in Google Scholar

Azzopardi, D., C. Lui, and J. Murphy: Chemical Characterisation of Tobacco-Free “Modern” Oral Nicotine Pouches and their Position on the Toxicant and Risk Continuums; BMC Chem. 45 (2021) 2246–2254. DOI: 10.1080/01480545.2021.1925691 AzzopardiD. LuiC. MurphyJ. Chemical Characterisation of Tobacco-Free “Modern” Oral Nicotine Pouches and their Position on the Toxicant and Risk Continuums BMC Chem 45 2021 2246 225410.1080/01480545.2021.1925691 Open DOISearch in Google Scholar

19. Levy, D.T., E.A. Mumford, K.M. Cummings, E.A. Gilpin, G. Giovino, A. Hyland, D. Sweanor, and K.E. Warner: The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts; Cancer Epidemiol. Biomarkers Prev. 13 (2004) 2035–2042. LevyD.T. MumfordE.A. CummingsK.M. GilpinE.A. GiovinoG. HylandA. SweanorD. WarnerK.E. The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts Cancer Epidemiol. Biomarkers Prev. 13 2004 2035 2042 Search in Google Scholar

20. Benowitz, N.L.: Nicotine Addiction; New Engl. J. Med. 362 (2010) 2295–2303. DOI: 10.1056/NEJMra0809890 BenowitzN.L. Nicotine Addiction New Engl. J. Med 362 2010 2295 230310.1056/NEJMra0809890 Open DOISearch in Google Scholar

21. Lunell, E., K. Fagerström, J. Hughes, and R. Pendrill: Pharmacokinetic Comparison of a Novel Non-Tobacco-Based Nicotine Pouch (ZYN) with Conventional, Tobacco-Based Swedish Snus and American Moist Snuff; Nicotine Tob. Res. 22 (2020) 1757–1763. DOI: 10.1093/ntr/ntaa068 LunellE. FagerströmK. HughesJ. PendrillR. Pharmacokinetic Comparison of a Novel Non-Tobacco-Based Nicotine Pouch (ZYN) with Conventional, Tobacco-Based Swedish Snus and American Moist Snuff Nicotine Tob. Res 22 2020 1757 176310.1093/ntr/ntaa068 Open DOISearch in Google Scholar

22. Plurphanswat, N., J.R. Hughes, K. Fagerström, and B. Rodu: Initial Information on a Novel Nicotine Product; Am. J. Addict. 29 (2020) 279–286. DOI: 10.1111/ajad.13020 PlurphanswatN. HughesJ.R. FagerströmK. RoduB. Initial Information on a Novel Nicotine Product Am. J. Addict 29 2020 279 28610.1111/ajad.13020 Open DOISearch in Google Scholar